A detailed history of Tcw Group Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Tcw Group Inc holds 403,638 shares of ABBV stock, worth $71.4 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
403,638
Previous 403,638 -0.0%
Holding current value
$71.4 Million
Previous $79.7 Million -0.0%
% of portfolio
0.71%
Previous 0.71%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $360,284 - $438,326
2,199 Added 0.55%
403,638 $79.7 Million
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $10.5 Million - $12.3 Million
68,087 Added 20.42%
401,439 $68.9 Million
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $1.17 Million - $1.33 Million
-7,319 Reduced 2.15%
333,352 $60.7 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $4.37 Million - $4.92 Million
31,748 Added 10.28%
340,671 $52.8 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $9.8 Million - $11.3 Million
-73,381 Reduced 19.19%
308,923 $46 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $3.05 Million - $3.79 Million
22,996 Added 6.4%
382,304 $51.5 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $4.96 Million - $5.71 Million
-34,297 Reduced 8.71%
359,308 $57.3 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $4.98 Million - $5.97 Million
36,010 Added 10.07%
393,605 $63.6 Million
Q3 2022

Oct 27, 2022

SELL
$134.21 - $153.93 $2.26 Million - $2.59 Million
-16,805 Reduced 4.49%
357,595 $48 Million
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $3.09 Million - $3.93 Million
-22,479 Reduced 5.66%
374,400 $57.3 Million
Q1 2022

Apr 19, 2022

BUY
$131.98 - $163.75 $985,890 - $1.22 Million
7,470 Added 1.92%
396,879 $64.3 Million
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $7.15 Million - $9.04 Million
66,538 Added 20.61%
389,409 $52.7 Million
Q3 2021

Oct 26, 2021

SELL
$106.4 - $120.78 $811,832 - $921,551
-7,630 Reduced 2.31%
322,871 $34.8 Million
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $1.69 Million - $1.89 Million
16,105 Added 5.12%
330,501 $37.2 Million
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $2.86 Million - $3.15 Million
27,955 Added 9.76%
314,396 $34 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $2.17 Million - $2.93 Million
27,002 Added 10.41%
286,441 $30.7 Million
Q3 2020

Oct 30, 2020

BUY
$85.91 - $100.83 $482,814 - $566,664
5,620 Added 2.21%
259,439 $22.7 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $7.82 Million - $10.5 Million
106,537 Added 72.34%
253,819 $24.9 Million
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $9.5 Million - $14.4 Million
147,282 New
147,282 $11.2 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $1.04 Million - $1.28 Million
-13,300 Closed
0 $0
Q3 2018

Oct 30, 2018

SELL
$88.91 - $98.84 $485,982 - $540,259
-5,466 Reduced 29.13%
13,300 $1.26 Million
Q2 2018

Aug 02, 2018

SELL
$89.78 - $106.23 $202,633 - $239,761
-2,257 Reduced 10.74%
18,766 $1.74 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $1.01 Million - $1.35 Million
-10,981 Reduced 34.31%
21,023 $1.99 Million
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $148,132 - $162,439
1,654 Added 5.45%
32,004 $3.1 Million
Q3 2017

Nov 06, 2017

BUY
$69.85 - $89.22 $1.03 Million - $1.31 Million
14,699 Added 93.92%
30,350 $2.7 Million
Q2 2017

Aug 11, 2017

BUY
N/A
15,651
15,651 $1.14 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tcw Group Inc Portfolio

Follow Tcw Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.